Advertisement
U.S. markets open in 6 hours 28 minutes
  • S&P Futures

    5,207.75
    -7.00 (-0.13%)
     
  • Dow Futures

    39,213.00
    -10.00 (-0.03%)
     
  • Nasdaq Futures

    18,183.00
    -48.50 (-0.27%)
     
  • Russell 2000 Futures

    2,047.00
    -2.80 (-0.14%)
     
  • Crude Oil

    82.51
    -0.21 (-0.25%)
     
  • Gold

    2,160.10
    -4.20 (-0.19%)
     
  • Silver

    25.13
    -0.14 (-0.53%)
     
  • EUR/USD

    1.0868
    -0.0008 (-0.08%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.33
    -0.08 (-0.56%)
     
  • GBP/USD

    1.2706
    -0.0022 (-0.18%)
     
  • USD/JPY

    150.3820
    +1.2840 (+0.86%)
     
  • Bitcoin USD

    64,895.14
    -3,560.97 (-5.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

GCANRx offers oral patch with cannabinoid, as vaping-related illnesses increase

Vaping related illnesses continue to rise, prompting the FDA and CDC to launch an investigation. Meanwhile, GCANRx thinks that it has a possible solution, a patch that releases a certain amount of cannabinoid each use. GCANRx CEO Aitan Zacharin joins On The Move to discuss.

Advertisement